Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Silence Therapeutics (SLN – Research Report) and keeping the price ...

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Silence Therapeutics (SLN – Research Report) and keeping the price target at $75.00. Patrick Trucchio has given his Buy ...

New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment ...

Phico Therapeutics, Technophage, and others are evaluating new phage therapies to improve the treatment landscape. Promising pipeline phage therapies such as LBP-EC01, AP-PA02, AP-SA02 ...

Promising endometriosis pipeline therapies such as Linzagolix ... In October 2024, Lisata Therapeutics, Inc. announced that it has entered into a sponsored research agreement with the University ...

(MENAFN- GlobeNewsWire - Nasdaq) Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic ...

New York, USA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Chronic Pain Clinical Trial Pipeline Experiences Momentum ... Centrexion Therapeutics, Neumentum Inc., Grünenthal, Synerkine Pharma, Intra ...

Request a sample and discover the recent advances in tuberculosis treatment drugs @ Tuberculosis Pipeline Report The tuberculosis pipeline report provides detailed profiles of pipeline assets ...

DelveInsight's dry AMD pipeline report depicts a robust space ... Belite Bio, Cognition Therapeutics, Aviceda Therapeutics, Stealth BioTherapeutics, Allergo Ophthalmics, Annexon, Inc., Johnson ...